Breast Neoplasms: all 12,820 studies

Page 44 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Vitamin D in Postmenopausal Women at High Risk for Breast CancerCompletedNCT00859651Phase 2Results posted
• S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerCompletedNCT00856492Phase 2Results posted
• Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast CancerCompletedNCT00853996Phase 2Results posted
• Low Level Laser Treatment and Breast Cancer Related LymphedemaCompletedNCT00852930Phase 4Results posted
• Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
• Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast CancerCompletedNCT00847171Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerCompletedNCT00846027Phase 2Results posted
• Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ PatientsCompletedNCT00841828Phase 2Results posted
• Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain MetastasesCompletedNCT00838929Phase 1Results posted
• Cytokine Expression During Radiation for Breast CancerCompletedNCT00836186Not applicableResults posted
• Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00834678Phase 1/2Results posted
• Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresTerminatedNCT00832338Phase 2Results posted
• A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerCompletedNCT00829166Phase 3Results posted
• Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is ProgressingCompletedNCT00828854Phase 2Results posted
• Using Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaCompletedNCT00828516Not applicableResults posted
• Sorafenib and Vinorelbine in Treating Women With Stage IV Breast CancerCompletedNCT00828074Phase 1/2Results posted
• Trial of RAD001 in Triple Negative Metastatic Breast CancerTerminatedNCT00827567Phase 2Results posted
• 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or TrastuzumabCompletedNCT00826267Phase 2Results posted
• Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast CancerCompletedNCT00825734Phase 1/2Results posted
• Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00824733Phase 2Results posted
• Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone MarrowTerminatedNCT00824538Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast CancerCompletedNCT00821886Phase 2Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerCompletedNCT00820872Phase 2Results posted
• Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerCompletedNCT00820222Phase 3Results posted
• Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194CompletedNCT00820170Phase 1/2Results posted
• Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer PatientsTerminatedNCT00817531Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast CancerCompletedNCT00811135Phase 2Results posted
• Exemestane in Treating Postmenopausal Women With Stage IV Breast CancerCompletedNCT00810797Phase 2Results posted
• Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast CancerTerminatedNCT00810017Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast CancerCompletedNCT00802945Phase 2Results posted
• A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast CancerCompletedNCT00798135Not applicableResults posted
• Trastuzumab in Treating Older Women With Early-Stage Breast CancerCompletedNCT00796978Phase 2Results posted
• A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast CancerTerminatedNCT00796107Phase 2Results posted
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantCompletedNCT00795769Phase 2Results posted
• Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerTerminatedNCT00793546Phase 2Results posted
• Vaccine Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT00791037Phase 1/2Results posted
• A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast CancerCompletedNCT00789581Phase 3Results posted
• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerCompletedNCT00785291Phase 3Results posted
• Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)CompletedNCT00784849Phase 2Results posted
• Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast CaTerminatedNCT00784524Phase 2Results posted
• Personalized Treatment Selection for Metastatic Breast CancerTerminatedNCT00780676Phase 2Results posted
• Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)TerminatedNCT00779285Phase 4Results posted
• Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast CancerTerminatedNCT00777335Phase 2Results posted
• Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast CancerCompletedNCT00777101Phase 2Results posted
• Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast CancerCompletedNCT00777049Phase 2Results posted
• An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With AromasinTerminatedNCT00776659Results posted
• S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoCompletedNCT00775645Phase 3Results posted
• Lonafarnib in Metastatic Breast CancerTerminatedNCT00773474Phase 2Results posted
• Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00770809Phase 3Results posted
• Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer SurgeryCompletedNCT00768222Phase 4Results posted
• Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast CancerCompletedNCT00767520Phase 2Results posted
• Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast CancerTerminatedNCT00765765Phase 1/2Results posted
• Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving TamoxifenCompletedNCT00764322Phase 2Results posted
• A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)CompletedNCT00759785Phase 1Results posted
• Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone TherapyTerminatedNCT00759642Phase 2Results posted
• Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast CancerCompletedNCT00756717Phase 4Results posted
• Phase II Neoadjuvant in Inflammatory Breast CancerTerminatedNCT00756470Phase 2Results posted
• Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor TherapyCompletedNCT00754845Phase 3Results posted
• L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast CancerTerminatedNCT00754767Phase 4Results posted
• Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase InhibitorCompletedNCT00754325Phase 2Results posted
• ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex TrialTerminatedNCT00752986Phase 2Results posted
• Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast CancerTerminatedNCT00751101Phase 2Results posted
• A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast CancerCompletedNCT00748553Phase 1/2Results posted
• A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)CompletedNCT00746694Results posted
• Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.TerminatedNCT00744653Phase 2Results posted
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast CancerCompletedNCT00741260Phase 1/2Results posted
• Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast CancerTerminatedNCT00739063Phase 2Results posted
• A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)CompletedNCT00736333Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast CancerCompletedNCT00728949Phase 2Results posted
• An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)CompletedNCT00726661Results posted
• Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast CancerTerminatedNCT00726180Phase 1/2Results posted
• Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNCT00723398Not applicableResults posted
• Cryoablation Therapy in Treating Patients With Invasive Ductal Breast CancerStatus unknownNCT00723294Phase 2Results posted
• Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast CancerCompletedNCT00723125Phase 2Results posted
• Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor TherapyTerminatedNCT00722072Phase 2Results posted
• Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast CancerCompletedNCT00721630Phase 2Results posted
• Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast CancerCompletedNCT00721409Phase 2Results posted
• Upper Extremity Lymphatic Mapping for Breast Cancer PatientsCompletedNCT00717886Not applicableResults posted
• A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.CompletedNCT00717405Phase 2Results posted
• Ultrasound Elastography of Breast LesionsCompletedNCT00716482Results posted
• Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)CompletedNCT00712985Phase 3Results posted
• Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast CancerCompletedNCT00712881Phase 2Results posted
• Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.CompletedNCT00711529Phase 3Results posted
• Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBCCompletedNCT00709761Phase 2Results posted
• Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer SubjectsTerminatedNCT00709618Phase 2Results posted
• BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast CancerCompletedNCT00708214Phase 2Results posted
• Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerCompletedNCT00706030Phase 1/2Results posted
• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerCompletedNCT00703326Phase 3Results posted
• Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 MutationsTerminatedNCT00700778Not applicableResults posted
• Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00699491Phase 1/2Results posted
• Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or MetastaticCompletedNCT00696072Phase 2Results posted
• Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast CancerCompletedNCT00694577Not applicableResults posted
• Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast CancerCompletedNCT00693719Phase 2Results posted
• Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast CancerCompletedNCT00691678Phase 2Results posted
• Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast CancerCompletedNCT00688909Phase 4Results posted
• Docetaxel in Node Positive Adjuvant Breast CancerCompletedNCT00688740Phase 3Results posted
• A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)CompletedNCT00687440Phase 2Results posted
• Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerCompletedNCT00684983Phase 2Results posted

← Breast Neoplasms overview